With recent advances in sequencing technology, it is now feasible to measure DNA methylation 11 at tens of millions of sites across the entire genome. In most applications, biologists are 12 interested in detecting differentially methylated regions, composed of multiple sites with 13 differing methylation levels among populations. However, current computational approaches for 14 detecting such regions do not provide accurate statistical inference. A major challenge in 15 reporting uncertainty is that a genome-wide scan is involved in detecting these regions, which 16 needs to be accounted for. A further challenge is that sample sizes are limited due to the costs 17 associated with the technology. We have developed a new approach that overcomes these 18 challenges and assesses uncertainty for differentially methylated regions in a rigorous manner. 19
Introduction 4
DNA methylation is an important epigenetic modification that plays a role in a wide variety of 5 biological processes. Numerous studies have been carried out to locate CpG loci where DNA 6 methylation may be involved in gene regulation, differentiation, and cancer. With recent 7 advances in sequencing technology such as Whole Genome Bisulfite Sequencing (WGBS), it is 8 now possible to measure DNA methylation at single base resolution across all CpGs in the 9 genome. Even though the most common application of the technology is to detect differentially 10 methylated regions (DMRs) between populations, most methods for analysis of WGBS 11 experiments focus on statistical differences for CpG loci one at a time (Akalin et al., 2012, 12 Dolzhenko and Smith, 2014, Lee and Morris, 2016, Park et al., 2014, Park and Wu, 2016) . While 13 useful, approaches for identification of differentially methylated loci (DML) have many practical 14 limitations in both implementation and interpretation. Here, we discuss these limitations as well 15 as outline the challenges of performing inference at the region level. Finally, we introduce a 16 rigorous statistical approach that overcomes these challenges to construct de novo DMRs with 17 accurate FDR control . 18 Methods to identify DMLs in WGBS experiments are greatly hindered by the high -19 dimensionality and low sample size setting that is common in high-throughput genomics studies. 20
The number of tests performed is equal to the number of loci analyzed, which is very large in 21 typical WGBS studies. In the human genome, for example, there are close to thirty million CpG 22 loci (Smith and Meissner, 2013) . Further, DML methods generally do not account for the well-23 known fact that measurements are spatially correlated across the genome (Leek et al., 2010) and instead treat measurements from all loci as independent. Correcting for multiple comparisons 1 without taking into account these correlations can result in a loss of power. 2 Additionally, methods for assessing the significance of DMLs typically require large 3 sample sizes due to reliance on large sample approximations (Dolzhenko and Smith, 2014, 4 Hansen, Langmead and Irizarry, 2012, Hebestreit, Dugas and Klein, 2013, Lee and Morris, 5 2016 ). Although WGBS is the current gold standard for estimating whole genome methylation 6 profiles (Marx, 2016) , cost limitations are still a barrier to acquiring more than a few individuals 7 per biological condition in many studies (Ziller et al., 2015) . This is reflected in the study design 8 of major consortiums that aim to characterize the epigenome. For example, WGBS experiments 9
in murine embryos carried out as part of the ENCODE project are limited to two biological 10 replicates per tissue type and developmental time point combination (He et al., 2017) . In 11 addition, the number of biological replicates measured with WGBS in the UCSD Human 12
Reference Epigenome Mapping Project (Schultz et al., 2015) is also limited to 2-3 per tissue 13 type. As such, we aim to maximize power while controlling the false discovery rate even with 14 sample sizes as small as two samples per condition. 15
Methods for identifying DMLs also need to properly model count data that does not 16 conform to standard Gaussian models. This is in contrast to methylation array analysis, where 17
Gaussian models performed well (Jaffe et al., 2012). One option is to assume that methylation 18
proportions, defined as the number of methylated reads divided by the number of total reads 19 covering a given CpG locus, follow a normal distribution (Hansen, Langmead and Irizarry, 20 2012) . However this assumption clearly does not hold when the total reads covering the CpG, 21 referred to as the coverage, is small, a common occurrence in these datasets. The approach also 22 ignores that variance of this proportion depends on the coverage. To overcome these limitations, 23 DML approaches have also modeled WGBS count data using Binomial models (Saito, Tsuji and 1 Mituyama, 2014). However, Binomial models on their own cannot account for biological 2 variability within sample groups. In order to account for biological variability in count data, 3
Beta-Binomial models , Sun et al., 2014 ) are a natural extension. However they 4 come at the cost of increased computational burden when testing millions of loci. 5
Beyond implementation challenges, DML approaches also suffer from limited 6 interpretability. In general, identifying DMRs is more biologically relevant than reporting DMLs. 7
Apart from the so-called 'CpG traffic lights' (Khamis et al., 2017) , most individual CpG loci 8 likely do not have a large impact on epigenetic function on their own, but rather through a 9 biochemical modification that involves several loci. Most notably, regional DNA methylation 10 levels are correlated with the expression levels of nearby genes. Specifically, methylation gain is 11 associated with stable transcriptional silencing of nearby genes (Bird, 2002) . In the context of 12 differential methylation analysis, Aryee et al. (2014) found that differentially expressed genes 13
were consistently more likely to be located near DMRs than DMLs. 14 While DML approaches may construct DMRs by chaining together neighboring 15 significant loci, this type of approach will not yield a proper assessment of the statistical 16 significance of the constructed regions, nor will the False Discovery Rate (FDR) be properly 17 controlled (Robinson et al., 2014) . This is because controlling the FDR at the level of individual 18 loci is not the same as controlling FDR of regions, as has been noted in the context of peak 19 calling in ChIP-seq experiments (Lun and Smyth, 2014, Siegmund, Zhang and Yakir, 2011). 20 FDR correction at the level of individual loci means that the proportion of expected false positive 21 loci is controlled, not the proportion of false positive regions. Statistically, this is a critical point 22 since FDR control of DMR detection is not guaranteed under the DML setting. In fact, many 23 discoveries at the loci level may constitute only a single discovery. This means that a large 1 number of correct rejections at the loci level can inflate the denominator in the FDR calculation, 2 which will artificially lower the false discovery rate of loci as compared to regions ( Figure 1 ). 3
We were motivated to develop a procedure to control FDR at the region level and provide an 4 accurate measure of statistical significance for each region. 5
Many recent computational approaches have been developed with the goal of identifying 6
DMRs, but most do not provide formal inference for regions (Hansen, Langmead and Irizarry, 7 2012, Saito, Tsuji and Mituyama, 2014, Wu et al., 2015, Yu and Sun, 2016) and instead join 8 together significant DMLs. This type of procedure will suffer from the problems outlined above. 9
Other approaches can perform inference at the region level, but only for predefined regions of 10 interest or fixed sliding windows (Hebestreit, Dugas and Klein, 2013, Sun et al., 2014) . Though 11 useful in targeted settings such as Reduced Representation Bisulfite Sequencing (RRBS), or 12 when we have prior knowledge of the DMR size, they are not applicable to identifying DMRs of 13 arbitrary size from WGBS. Those methods that scan the genome for DMRs and provide 14 inference at the region level do not properly control FDR (Juhling et al., 2016 , Wen et al., 2016 . 15 This is evidenced, for example, by the FDRs reported in the simulation studies of Wen et al. 16 (2016) , which were as high as 0.85 and widely varied across scenarios. Juhling et al. (2016) also 17 do not achieve accurate FDR control in simulation studies (see Section 4.1). 18
The challenge of performing inference at the region level is complicated by several 19 factors in addition to the challenges already discussed in the context of DML analysis. The first 20 challenge is in defining the region boundaries themselves. Without prior knowledge or 21 predefined regions, we need to construct data-driven regions. Calculating a test statistic for these 22
data-driven regions of varying sizes with a known null distribution is not straightforward. In 23 addition, challenges are presented by the complex statistical dependencies observed in 1 measurements from nearby loci (Benjamini, Taylor and Irizarry, 2016), as well as different 2 within group variability across loci (Hansen, Langmead and Irizarry, 2012). Some methods 3 ignore correlation across loci (Wen et al., 2016) or biological variability from sample to sample 4 (Saito, Tsuji and Mituyama, 2014, Wu et al., 2015) . Not properly accounting for both of these 5 sources of variability in DNA methylation data, however, results in misleading conclusions or 6 loss of power. For a full review of DML and DMR methods, see Shafi et al. (2017) . 7
To overcome the limitations and challenges detailed above, we propose a two-stage 8 approach that first detects candidate regions and then explicitly evaluates statistical significance 9 at the region level while accounting for known sources of variability. Candidate DMRs are 10 defined by segmenting the genome into groups of CpGs that show consistent evidence of 11 differential methylation. Because the methylation levels of neighboring CpGs are highly 12 correlated, we first smooth the signal to combat loss of power due to low coverage as done by 13
Hansen, Langmead and Irizarry (2012). In the second stage, we compute a statistic for each 14 candidate DMR that takes into account variability between biological replicates and spatial 15 correlation among neighboring loci. Significance of each region is assessed via a permutation 16 procedure which uses a pooled null distribution that can be generated from as few as two 17 biological replicates, and false discovery rate is controlled using the procedure of Benjamini and 18 Hochberg (1995) . Code to reproduce the analyses presented in this paper is provided in 19
Supplementary material and the open-source R package dmrseq that implements the approach is 20 available on GitHub. 21
In Section 2, we provide a detailed description of the datasets used. We describe the 22 methodological details of the approach and detail the data processing and analysis procedure in 23 Section 3. In Section 4, we present our findings using both experimental data and simulations. 1
We demonstrate that the proposed approach assigns greater statistical significance to regions that 2 have greater biological significance in terms of potential functional roles in the regulation of 3 gene expression. We also evaluate sensitivity and specificity of the approach by analyzing null 4 comparisons of samples from the same biological condition, with and without adding simulated 5
DMRs. We demonstrate that dmrseq has higher sensitivity than existing approaches and 6 accurately assesses statistical significance of regions through False Discovery Rate estimation. A 7 discussion of the advantages and limitations of the method are given in Section 5. 8 9
Data Description 10
dmrseq is generally applicable to WGBS data which contains the counts for both methylated and 11 unmethylated reads mapping to each CpG loci. This information can be obtained from raw 12 sequencing reads using the mapping software Bismark (Krueger and Andrews, 2011), as 13 described in the Supplementary materials. Specifically, CpG loci that are covered by at least one 14 read in every sample should be used in the analysis. Other methods for analysis of WGBS data 15 recommend removing CpG sites that have only a few reads in each sample, and while processed 16 data of this form may be analyzed by our approach, it is important to note that this may result in 17 a loss of power to detect regions in low-coverage areas of the genome. 18
In this study, we use our approach to identify DMRs using publically available WGBS 19 data from two different case studies, as described below. We also evaluate sensitivity and 20 specificity of DMR methods by applying them to simulated data. Summary of coverage and 21 methylation values for all datasets used can be found in Table 1 and Supplementary Figure S2 . 22 For more details on data processing, see Section 1 of the Supplementary materials. 23
Simulated data 1
Two sets of simulated data were constructed: one representing a null comparison (with no 2 DMRs) and another containing simulated DMRs. To ensure that the simulated datasets closely 3 match the characteristics of the observed experimental data, they were generated based on 4 WGBS data from a study of human dendritic cells (Pacis et al., 2015) . This study estimated 5 methylation profiles of human dendritic cells from six donors before and after infection with a 6 pathogen. The null comparison was constructed by randomly partitioning the six control samples 7 (before infection) into two groups of three samples each, denoted Simulation N3. The same is 8 done for a subset of four of the samples to evaluate performance when there are only two 9 samples in each population, denoted Simulation N2. 10
Starting with the null comparisons, 3,000 simulated DMRs were added to each dataset in 11 order to evaluate specificity and sensitivity. These are denoted Simulations D2 and D3 for two 12 and three samples per population, respectively. Briefly, a DMR is constructed by sampling a 13 cluster of neighboring CpGs and simulating the number of methylated reads, conditional on 14 observed coverage, for the samples from one population from a binomial distribution. The 15 binomial probabilities are equal to the observed methylation proportions plus or minus a 16 randomly sampled difference, which varies smoothly over the region according to a function 17 similar to the tricube kernel (Cleveland, 1979) (see Section 2.4 of the Supplementary materials). 18 19 and a duplication of the FLT3 locus has been shown to induce ALL. The mouse model with the 10 same duplication of the FLT3 locus as well as a knock out of DNMT3a has been shown to 11 induce the more lethal and aggressive AML. The DNMT3a also plays a role in promoting DNA 12 methylation, so it is of interest to characterize the resulting differences in methylated regions 13 among the control and two different leukemia models. 14 15
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Analysis Framework 16
A two-step procedure is carried out to (1) construct de novo candidate regions, and (2) score 17 candidate regions to quantify the effect of the covariate of interest on methylation level, and 18 evaluate statistical significance by comparing them to null regions. Here we detail each stage of 19 the approach. 20 21
Construction of candidate regions
In step 1, we detect candidate regions that contain multiple loci showing evidence of a difference 1 in the smoothed pooled methylation proportion between biological conditions. For simplicity of 2 presentation, we assume there are two biological conditions ∈ 1,2 , with sample indices 3 ∈ ! (see Supplementary materials Section 2.7 for the case of more than two conditions). Let 4 !" be the number of methylated reads and !" the number of unmethylated reads for locus of 5 sample from condition . The coverage is denoted !" , where !" = !" + !" . The estimate of 6 the mean methylation proportion !" for loci in condition is taken to be the sum of methylated 7 reads from all samples in that condition divided by the sum of all reads (i.e. the coverage) from 8 all samples in condition : 9
This leads to the following estimate of methylation proportion difference ! between condition 10 and ′ at loci : 11
In order to give more weight to measurements with higher coverage, this estimate pools together 12 samples within the same condition. To account for biological variability between samples and 13 further reduce influence of observations with low coverage, smoothed individual loci estimates 14 ! !"##$! are obtained using a local-likelihood smoother (Loader, 1999) with smoothing weights 15 ! equal to the median coverage at loci scaled by the average Median Absolute Deviation 16 (MAD) within the sample groups ! : 17
This places more emphasis on observations with high coverage and low variability within sample 20 group (see Section 2.1 of the Supplementary material for more details). 21
Candidate regions are defined by segmenting the genome into groups of loci with a 1 smoothed and scaled pooled proportion difference ! !"##$! ! ( ! ) in the same direction that is 2 greater than some threshold in absolute value (refer to Supplementary materials Section 2.2 for 3 more details). Maximum spacing between loci within a candidate region is controlled by a 4 predetermined value, and loci at the start and end of the region with low difference values are 5 trimmed (refer to Supplementary materials Section 2.3 for more details). The threshold value 6 should be chosen liberally so that it will more or less capture all of the true differences without 7 regard to false positives, as significance of the candidate regions is assessed in the next step. 8 9
Assessing significance of regions 10
In the second step, we assess the significance of candidate regions. This task is complicated by 11 the fact that the null statistics are calculated on an enriched set of regions. In general, the null 12 distribution generated by the type of selection procedure described in the previous section is not 13 known. A natural approach would be to carry out a permutation test to control FWER (family-14 wise error rate), which is done by Jaffe et al. to detect DMRs is greatly reduced in simulation studies (Supplementary Figure S5 and 5
Supplementary materials Section 4.1). 6
Since we need to compute the statistic over potentially hundreds of thousands of 7 candidate regions, we also favor an approach that provides efficient and stable estimation 8 procedures. For these reasons, we make use of generalized least squares (GLS) regression model 9 with a nested autoregressive correlated error structure for the effect of interest on transformed 10 methylation proportions, the advantages of which are described in detail in the next subsections. 11 12
Estimation of region statistics with Generalized Least Squares models 13
To account for sampling variability, we assume that methylation counts for region are 14
Binomially-distributed with probability !"# , where 15
To model biological variability, we allow the binomial proportion for samples in condition 17 ∈ 1,2 to vary according to a beta distribution with shape parameters !"# and !"# , where 18
denote the mean of this Beta distribution. We are interested in estimating and 20 assessing the significance of the difference in mean methylation levels across a region for two 21 biological conditions. 22
Our approach models transformed methylation proportions using GLS to obtain an 1 approximation of the effect of interest. While directly modeling counts with either a Beta-2 Binomial Generalized Linear Model (GLM) or a Generalized Linear Mixed Model (GLMM) 3 would allow us to accommodate complex covariance structures across samples and loci, it also 4 results in complex likelihoods that require iterative maximization for each candidate region. 5
Further, these procedures are subject to instability of estimation for methylation levels near the 6 boundaries (zero and one) or non-identifiability in the case of separation as they occur in GLM 7 (Gelman et al., 2008) and GLMM (Abrahantes and Aerts, 2012) estimation. GLS models, in 8 contrast, are efficient and stable to estimate due to the availability of approximate closed-form 9 parameter estimates. Though GLS does not model counts directly, we incorporate information 10 lost after transformation of methylation proportions through specification of a variance estimate 11 that depends on coverage. 12
We choose the arcsine link function !"# = 2 !"# !"# − 1 to obtain 13 transformed methylation proportions, as proposed by (Park and Wu, 2016) for DML analysis, for 14 its desirable ability to stabilize the dependence of the variance on the mean methylation level. 15
While the variance of methylation proportions !"# !"# depends on the mean parameter !"# , 16 the variance of !"# only depends on coverage !"# and the dispersion of the Beta-Binomial 17 distribution (refer to Supplementary materials Section 2.6 for more details). This helps us to form 18 a statistic involving the transformed proportions that is exchangeable across regions that have 19 different mean methylation values. 20
We assume a linear effect on the arcsine link-transformed methylation proportion 21 parameters: 22
Here !!" are loci-specific intercept terms that account for variation on overall methylation levels 1 across the region, where = 1, … ! and ! denotes the number of loci in region . The 2 coefficient for the effect of interest (e.g. biological group) is !! . We denote the design matrix as 3 and the ( ! + 1)-length vector of all coefficients !"! , !"! , … , !! ! ! , !! as ! . This leads 4 to the following model for the transformed response
where we assume that = 0 and = ,which can be fit by GLS given an estimate 6 of the covariance matrix . Since GLS allows arbitrary covariance structures, we use an 7 autoregressive correlation structure to account for the correlation of methylation levels among 8 nearby loci. To account for the dependence of the variance on coverage as mentioned above, we 9 use variance weights. More details on the specific structure and estimation of are given in the 10 next section. 11
With the above model, we assess the strength of the effect of the covariate of interest on 12 methylation level within region using the t-statistic ! from the Wald test of the null hypothesis 13 that !! = 0. Parameter estimates and their standard errors are obtained with the `gls` function in 14 the `nlme` package (Pinheiro et al., 2017) . Significance is evaluated by permutation using a 15 pooled null distribution as described in detail in Section 3.2.3. 16 17
Covariance of methylation levels within regions 18
In the estimation of the covariance matrix , we take into account biological variability through 19 variance weighting, and correlation of nearby loci through an autocorrelation structure. The 20 variance weighting is done to account for the dependence of the variance of transformed values !"# on coverage. This variance depends non-linearly on !"# (Supplement Section 2.6), but in 1 order to enable efficient closed-form estimation with GLS, we further approximate it by 2
In addition, in order to construct a valid permutation test where the variance conditional on the 3 effect of interest is invariant to permutation, we assume this variance identical for all samples at 4 a given loci by approximating !"# by ! !"# = !.! . 5
To model correlation of nearby loci, we use the flexible continuous autoregressive 6 correlation structure of order 1, abbreviated CAR(1). Under CAR(1), the correlation parameter 7 depends on the length of the interval between the two observations considered in the following 8
where is the length of the interval between two observations and ! is the positive continuous-10 time autoregressive coefficient (following the notation of Jones and Boadi-Boateng (1991)) for 11 region . Thus, for subject , the predicted methylation value for loci at location !"# in region 12 given the methylation value at loci − 1 is 13
If the error variance of the CAR1 process is !"
, and we let the correlation structure be 14 nested within subject (i.e. such that observations from two subjects are independent), it follows 15 that the covariance matrix for a given sample can be written
and for two subjects and ′,
The estimation of ! is computationally efficient to carry out on small to moderately sized 2 regions. However, for larger regions with more than 40 loci we use the slightly simpler AR(1) 3 correlation structure since it is many times faster to compute. This discrete formulation assumes 4 that observations are equally spaced, and that observations that are separated by lag 1 are 5 correlated with region-specific correlation parameter ! . In addition, observations that are 6 separated by positions are correlated by ! ! . This results in a covariance matrix for from 7 region , subject of 8
and again we assume that for two subjects and ′, !"# , !" ! ! = 0. 10
The CAR(1) structure simplifies to the AR(1) process under certain conditions when 11 observations are equally spaced (Jones and Boadi-Boateng, 1991). Thus the discrete AR(1) can 12 be viewed as an approximation of the CAR(1) when correlations are positive and the two provide 13 increasingly more similar estimates as observations approach constant spacing. Indeed, when 14 comparing model fits under both correlation structures in simulated data, the t-statistics for the coefficient of interest under CAR(1) generally converge to the estimates under AR(1) as the 1 number of loci increases (Supplementary Figure S1 and Section 2.5). 2 3
Permutation to generate a null set of regions 4
The values of the covariate of interest (e.g. biological group) are permuted and the previous steps 5 repeated in order to generate a set of statistics under the null hypothesis. Since the statistics 6 account for known sources of variation that would otherwise prevent to comparison of regions 7 across the genome, we can pool them together to form an approximate null distribution with as 8 few as two samples per population. The empirical p-value is calculated by comparing the 9 observed test statistics to the entire null set of statistics from all permutations. Control of FDR is 10 carried out by adjusting the p-values using the procedure of Benjamini and Hochberg (1995). 11 12
Results 13
For each of the datasets described in Section 2, we applied dmrseq, as well as three widely used 14 methods for DMR detection: BSmooth (Hansen, Langmead and Irizarry, 2012), DSS (Park and 15 Wu, 2016) , and metilene (Juhling et al., 2016) . Each approach was evaluated based on the 16 criteria detailed in the next subsections. For specific details on software implementation, refer to 17 the Supplementary materials (Section 3). 18 19
Simulation using dendritic cell data 20
Specificity was evaluated by identifying DMRs in null comparisons of two (N2) and three (N3) 21 samples per group. Sensitivity was evaluated by identifying simulated DMRs in comparisons of 22 two (D2) and three (D3) samples per group. Performance of each method is assessed by its 23 ability to identify as many of the simulated DMRs as possible, while identifying as few DMRs as 1 possible in the null comparison. 2 dmrseq did not identify any DMRs at the 0.05 level for the null comparisons N2 or N3 3 (Table 2 ). This remains true even when increasing the FDR threshold to 0.5 in both settings. In 4 contrast, metilene identified a small number of DMRs, DSS identified many hundreds, and 5
BSmooth tens of thousands using default settings (specific parameter specifications provided in 6
Supplementary materials Section 2.6). When applied to the datasets with simulated DMRs (D2 7 and D3), dmrseq is able to accurately control the False Discovery Rate, whereas metilene cannot 8 (Figure 2, Supplementary Figure S3 ). Note that analogous results cannot be obtained from DSS 9 or BSmooth, as there is no way to specify FDR level. 10
BSmooth and DSS identify similar numbers of False Positive regions in D2 and D3 11 compared to the null setting of N2 and N3, and far more than dmrseq and metilene ( Table 3) . 12
Although both BSmooth and DSS have favorable numbers of TPs, it is clear that this comes at 13 the expense of lack of control of FDR (Figure 3) . Similarly, metilene has favorable numbers of 14
FPs, but this comes at the expense of low power. Further, even at similar observed FDR levels, 15 dmrseq achieves higher power levels than the alternative methods. 16
Although FDR thresholds are not available for BSmooth or DSS, we also investigated the 17 sensitivity and specificity of other settings beyond defaults of the thresholds at the single-loci 18 level (the loci t-statistic cutoff for BSmooth, and the loci p-value for DSS). Making these 19 thresholds more conservative generally reduced the numbers of False Positives, but once again 20 dmrseq was consistently able to identify more True Positives at similar numbers of False 21
Positives (See Supplementary Results and Figure S4 ). 22 We also stress that although lower False Positive rates could be achieved in this 1 simulation study for BSmooth and DSS, individual loci thresholds do not correspond directly to 2 specific FDRs at the region level. As a result, in practice, one must choose a threshold either by 3 default settings, or by trial and error. 4 To qualitatively assess the ability of the dmrseq region-level summary statistic to rank 19
DMRs as compared to other methods, we display example regions from the human tissue and 20 murine leukemia studies. These examples illustrate the increased variability of regions that are 21 highly ranked by naïve statistics but not dmrseq ( Figure 5 ). We include a DMR with concordant 22 rankings that exhibits clear differences between two human tissue types ( Figure 5A) . In contrast, 23 the regions with discordant rankings between dmrseq q-value and mean difference ( Figure 5B ) 1 and area statistics ( Figure 5C) Supplementary Table S2 ), but DSS generally found far more 7
DMRs and metline far fewer. For BSmooth, however, the number of DMRs identified was 8 similar for all comparisons. This happens because the cutoff for the individual loci statistics is set 9 by default at a quantile of the observed statistics, resulting in a similar number of loci being 10 deemed significant. 11
The tissue-specific DMRs found by dmrseq are enriched for inverse associations with DE 12 genes, and this enrichment is stronger for DMRs with lower FDRs (Figure 4) . Additionally, 13 enrichment of dmrseq DMRs is generally stronger than that of alternative methods. While 14 metiline also provides an FDR estimate, there is no consistent association between the FDR 15 ranking and strength of association with expression. DMRs identified by BSmooth and DSS 16 cannot be ranked by FDR and the default settings may not be ideal, so we also rank DMRs by 17 effect size (raw methylation difference) with optimized parameter settings (see Supplementary  18 materials Section 3.2). The BSmooth and DSS DMRs with highest effect sizes exhibit 19 comparable enrichment to dmrseq, with metilene considerably lower ( Supplementary Figures S6  20 and S7). However, arbitrary cutoffs of effect size do not directly correspond to significance level, 21 and the enrichment when including all DMRs is highest for dmrseq ( Figure 4 ). 22
DNMT3a loss in murine leukemia models 1
In the murine leukemia models, dmrseq finds the most DMRs in the comparison of AML and the 2 control (Table 5) , which is also the comparison for which the most DE genes were identified (see 3 Supplementary Table S4 ). In contrast, DSS and metline both find the most DMRs in the 4 comparison with the fewest DE genes identified, and BSmooth identified similar numbers of 5 DMRs in each comparison, each with far more DMRs than the other methods. 6
The murine leukemia DMRs found by dmrseq are enriched for inverse associations with 7 DE genes, and this enrichment is stronger for DMRs with lower FDRs (Figure 4 ). Additionally, 8 enrichment is generally stronger than that of BSmooth, DSS, and metline. While metiline also 9 provides an FDR estimate, there is no consistent association between the FDR ranking and 10 strength of association with expression. Similar to the tissue specificity analysis, BSmooth and 11 DSS DMRs with highest effect sizes exhibit comparable enrichment to dmrseq, with metilene 12 considerably lower, and the enrichment when including all DMRs often drops lower for 13 BSmooth, DSS, or metline than for dmrseq ( Supplementary Figures S8 and S9) . 14 15
Discussion 16
We have described dmrseq, a method useful for discovering and prioritizing DMRs from WGBS 17 data. The approach is based on rigorous statistical reasoning and is the first method that permits 18 accurate inference on DMRs that are found by scanning the genome. By developing a 19 transformation that results in summary statistics from candidate regions being exchangeable, we 20 are able to borrow strength across the genome to build a null distribution that permits inference 21 with a sample size as small as 2. We have demonstrated how the method clearly outperforms Example regions from the human tissue and murine leukemia studies are displayed for three cases that illustrate the increased variability of regions that are highly ranked by area or mean difference statistics of BSmooth and DSS but not dmrseq. For each case, the q-value is shown for dmrseq and metiline, and the rank percentile by the area statistic and mean difference statistics are both shown for BSmooth and DSS (see Supplement Section 2.8 for details). (A) All methods assign a consistently high rank. (B) dmrseq assigns a low rank, but the mean difference statistic of BSmooth and DSS assign a high rank. (C) dmrseq assigns a low rank, but the area statistic of BSmooth and DSS assign a high rank. The condition comparison is indicated by the labels to the right of each plot. 
